BIOPROGNOSTIC

WIPO WIPO 2022

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark BIOPROGNOSTIC was filed as Word mark on 01/11/2022 at the World Intellectual Property Organization.

Trademark Details Last update: June 13, 2023

Trademark form Word mark
File reference 1658287
Countries Australia Brazil Canada Switzerland China Colombia em United Kingdom Israel India Japan South Korea Mexico Norway New Zealand Russia Singapore
Base trademark US No. , September 4, 2024
Application date January 11, 2022
Expiration date January 11, 2032

Trademark owner

1460 Broadway
New York NY 10036
US

Trademark representatives

1299 Pennsylvania Ave., NW, Suite 700 Washington DC 20004 US

goods and services

05 Medical diagnostic blood testing reagents and assays for predicting, identifying and determining the presence and stage of kidney, heart, and liver diseases and kidney, heart, and liver health; diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in kidney, heart, and liver health testing and disease prediction
10 Blood test collection kit comprised of blood collection bag, holder for medical sample tubes, vials, and test trips, and medical sample tubes, vials, and test strips for predicting, identifying and determining the presence and stage of kidney, heart, and liver diseases and kidney, heart, and liver health
42 Development of new technology for others in the field of medical devices and medical diagnostic apparatuses for predicting, identifying and determining the presence and stage of kidney, heart, and liver diseases and kidney, heart, and liver health; research, development and consultation related thereto in the field of medical devices and medical diagnostic apparatuses through the use of artificial intelligence; laboratory research in the field of kidney, heart, and liver health and kidney, heart, and liver diseases; medical research services relating to kidney, heart, and liver health; research and development services in the field of antibodies relating to kidney, heart, and liver health; computer software development; providing temporary use of on-line non-downloadable software and software applications using artificial intelligence for medical analysis; providing temporary use of on-line non-downloadable software and software applications for creating analytic and statistic models for data analysis in the field of kidney, heart, and liver health and kidney, heart, and liver disease
44 Medical profile and medical record analysis designed to provide patients with custom tailored information about the range of possible diagnoses and therapies associated with kidney, heart, and liver health and kidney, heart, and liver disease

Trademark history

Date Document number Area Entry
June 5, 2023 2023/23 Gaz KR Rejection
May 27, 2023 2023/22 Gaz NO Rejection
May 11, 2023 2023/19 Gaz MX Rejection
May 8, 2023 2023/19 Gaz IL Rejection
March 31, 2023 2023/14 Gaz RU RAW: Rule 18ter(2)(ii) GP following a provisional refusal
March 10, 2023 2023/14 Gaz SG Rejection
March 10, 2023 2023/11 Gaz CH Rejection
February 24, 2023 2023/11 Gaz BR Rejection
February 16, 2023 2023/7 Gaz JP Rejection
December 20, 2022 2022/51 Gaz CO Rejection
December 13, 2022 2022/50 Gaz NO Rejection
November 2, 2022 2022/45 Gaz EM Rejection
October 12, 2022 2022/41 Gaz GB Rejection
September 6, 2022 2022/38 Gaz IL Rejection
August 25, 2022 2022/34 Gaz CN Rejection
August 13, 2022 2022/34 Gaz NZ Rejection
August 5, 2022 2022/32 Gaz RU Rejection
July 12, 2022 2022/28 Gaz AU Rejection
May 17, 2022 2022/22 Gaz IN Rejection
January 11, 2022 2022/15 Gaz US Registration

ID: 141658287